Literature DB >> 22763245

Urinary tract fistulas in radical surgery for cervical cancer: the importance of early diagnosis.

P Karkhanis1, A Patel, K Galaal.   

Abstract

BACKGROUND: Urinary fistulas are a well-recognised complication of radical gynaecological oncology surgery for cervical cancer. Reported incidence varies between 0.6 and 5.1%.
METHODS: A retrospective case-note review of vesical and ureteric fistulas diagnosed in cases that underwent radical surgery for the new diagnosis of early stage cervical cancer between January 2000 and June 2010.
RESULTS: A total of 323 radical procedures for cervical cancer were performed during the study period. There were nine urinary tract fistulas found in eight women undergoing radical surgery for stage 1b1 cervical cancer, giving an incidence of 2.7%. Haemorrhage was the commonest associated factor and the commonest presenting symptom for fistula was leaking of urine per vagina. The fistulas were managed conservatively or surgically depending on their nature and severity. The longer the delay in confirming the diagnosis and initiating treatment the more severe were the long-term symptoms and morbidity.
CONCLUSION: Identification of predisposing factors, high index of suspicion, early investigations and multidisciplinary team management of urinary tract fistula are necessary to reduce post-operative morbidity and minimise renal loss.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22763245     DOI: 10.1016/j.ejso.2012.06.551

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  3 in total

Review 1.  Urological complications after treatment of cervical cancer.

Authors:  Esther M K Wit; Simon Horenblas
Journal:  Nat Rev Urol       Date:  2014-01-28       Impact factor: 14.432

2.  Simultaneously Diagnosed and Successfully Treated Rectovaginal and Vesicovaginal Fistulae after Low Anterior Resection with Concomitant Resection of Female Genitalia.

Authors:  Chisato Takagi; Hideo Baba; Kazuo Yamafuji; Atsunori Asami; Kaoru Takeshima; Nobuhiko Okamoto; Hidena Takahashi; Kiyoshi Kubochi
Journal:  Case Rep Gastroenterol       Date:  2017-01-27

3.  Incidence of fistula occurrence in patients with cervical cancer treated with bevacizumab: data from real-world clinical practice.

Authors:  Toru Sugiyama; Noriyuki Katsumata; Takafumi Toita; Masako Ura; Ayaka Shimizu; Shuichi Kamijima; Daisuke Aoki
Journal:  Int J Clin Oncol       Date:  2022-06-27       Impact factor: 3.850

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.